Clinical Trials
516 trialsFemale Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment
University Hospital, Geneva
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Boehringer Ingelheim
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
ModernaTX, Inc.
VICTORIE
Pfizer
Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)
Northwestern University
GLORIOSA
AbbVie
ROR
Abramson Cancer Center at Penn Medicine
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics, Inc.
TELE-CACHE
King Edward Medical University
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
National Institutes of Health Clinical Center (CC)
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial
National Institutes of Health Clinical Center (CC)
Smoking Cessation Treatment for Head & Neck Cancer Patients
M.D. Anderson Cancer Center
Gulf Long-Term Follow-Up Study
National Institutes of Health Clinical Center (CC)
M7824 Related Adverse Effects in Adults With Cancer
National Institutes of Health Clinical Center (CC)
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
Eli Lilly and Company
ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
H. Lee Moffitt Cancer Center and Research Institute
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Hoffmann-La Roche
Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
M.D. Anderson Cancer Center
APADHOP
University Hospital, Grenoble
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
MedImmune LLC
FOREFRONT
AstraZeneca
A Study of a Telemedicine Program for Older Adults With Cancer
Memorial Sloan Kettering Cancer Center
BfedBwell Optimization Pilot
University of Colorado, Denver
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data
National Institutes of Health Clinical Center (CC)
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
ACTIVE
Universität Duisburg-Essen
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
SaLuDo
PharmaMar
LADOGA
AstraZeneca
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Amgen
Yoga to Improve Disparities in Cancer Survivorship
University of California, San Francisco
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
BioNTech SE
PATHFINDER 2: A Multi-Cancer Early Detection Study
GRAIL, Inc.
Cancer-associated Cachexia in Patients With Incurable Gastroesophageal Cancer
Rigshospitalet, Denmark
Education and Health in Women With Cervical Cancer
Federal University of Maranhao
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
National Cancer Institute (NCI)
Dance Intervention in Breast Cancer Treatment
Federal University of Maranhao
CISTO
University of Washington
CZAR-1
University of Ulm
SABRE
Boston Scientific Corporation
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
National Hospital Organization Nagoya Medical Center
PROGRESS
Università Vita-Salute San Raffaele
OPAL
Janssen Biotech, Inc.
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
Janssen Research & Development, LLC
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Sanofi
PALOMA
Janssen Research & Development, LLC
Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer
Centre Hospitalier Universitaire Vaudois